Work

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non–Small-Cell Lung Cancer

Year: 2016

Type: article

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2016.11.006

Authors: Matthew S. Lara, William S. Holland, Danielle Chinn, Rebekah A. Burich, Primo N. Lara, David R. Gandara, Karen Kelly, Philip C. Mack

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: G776903742

OpenAlex ID: W2551486460

FWCI: 3.452

Cites: 31

Cited by: 40

Related to: 10